This Public Health England resource contains data and findings from the hepatitis C patient registry and treatment outcome system. Data from the registry shows that DAA treatments have successfully cured 95% of patients who received them. The vast majority of treatment continues to take place within secondary care, with just 13% of treatments undertaken in drug services, prisons or other outreach settings.
Good practice case study: Edinburgh Access Practice outreach service
Download
This HCV Action good practice case study focuses on Edinburgh Access Practice's outreach service, offering testing and treatment for hepatitis C to the homeless population. In the period from March 2014 to December 2016, of the 80 referrals received, 59 patients attended (70%) and 25 started treatment, compared with typical hospital clinical attendance rates of 30-50%. From January 2017 to June 2018 use of DAAs have enabled a further 52 patients to receive treatment at the EAP over the course of just 18 months. Many of the SVR tests results are awaited but early indications demonstrate good adherence and response rates.
